Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Ledipasvir/sofosbuvir

Delayed type hypersensitivity: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat McPhie ML, et al. Delayed-Type Hypersensitivity Reaction to Red Tattoo Ink Triggered by Ledipasvir/Sofosbuvir for Hepatitis C: A Case Report. Case Reports in Dermatology 13: 379-383, No. 2, 16 Jul 2021. Available from: URL: http://doi.org/10.1159/000513926 McPhie ML, et al. Delayed-Type Hypersensitivity Reaction to Red Tattoo Ink Triggered by Ledipasvir/Sofosbuvir for Hepatitis C: A Case Report. Case Reports in Dermatology 13: 379-383, No. 2, 16 Jul 2021. Available from: URL: http://​doi.​org/​10.​1159/​000513926
Metadaten
Titel
Ledipasvir/sofosbuvir
Delayed type hypersensitivity: case report
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-16039-5

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Rituximab

Case report

Azd-1222

Case report

Pheniramine

Case report

Multiple drugs